Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,670 | 15,850 | 10,790 | 11,100 | 11,870 |
| Receivables | 60 | 130 | 80 | 80 | 90 |
| Other current assets | 10 | 50 | 50 | 20 | 30 |
| TOTAL | $9,740 | $16,030 | $10,920 | $11,200 | $11,990 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $12,320 | $19,990 | $13,440 | $13,720 | $14,590 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,490 | 2,160 | 570 | 250 | 400 |
| TOTAL | $1,490 | $3,210 | $570 | $250 | $400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 90 | 0 | 90 | 90 | 100 |
| Other Non-Current Liabilities | 410 | 0 | 600 | 620 | 660 |
| TOTAL | $500 | $N/A | $690 | $710 | $760 |
| Total Liabilities | $2,010 | $3,210 | $1,280 | $980 | $1,170 |
| Shareholders' Equity | |||||
| Common Shares | 15,380 | 23,280 | 14,790 | 14,500 | 14,560 |
| Retained earnings | -6,690 | -9,000 | -4,250 | -3,400 | -2,820 |
| TOTAL | $10,300 | $16,780 | $12,160 | $12,730 | $13,420 |
| Total Liabilities And Equity | $12,310 | $19,990 | $13,440 | $13,710 | $14,590 |